Table 1. Patient and Tumor Characteristics.
Variable | MMS (n = 277) |
WLE (n = 385) |
P Value |
---|---|---|---|
Age, mean (SD), y | 64.0 (13.1) | 58.5 (15.6) | <.001 |
Sex, No. (%) | |||
Male | 172 (62.1) | 211 (54.8) | .06 |
Female | 105 (37.9) | 174 (45.2) | |
Race, No. (%) | |||
White | 252 (91.0) | 354 (91.9) | .66 |
Other/unknown | 25 (9.0) | 31 (8.1) | |
Year of diagnosis | |||
Mean (SD) | 2007 (3.9) | 2003 (5.6) | <.001 |
Median (range) | 2008 (1986-2013) | 2003 (1978-2013) | |
Tumor diameter,a cm | |||
Mean (SD) | 1.8 (1.5) | 1.6 (1.1) | .21 |
Median (IQR) | 1.4 (0.5-9.0) | 1.3 (0.1-8.3) | |
Anatomic site, No. (%)b | |||
Face | 222 (80.2) | 141 (36.7) | <.001 |
Scalp/neck | 23 (8.3) | 26 (6.8) | |
Trunk | 10 (3.6) | 73 (19.0) | |
Upper extremity | 13 (4.7) | 85 (22.1) | |
Lower extremity | 9 (3.2) | 59 (15.4) | |
WLE surgical margins, mean (SD), cm | NA | 0.6 (0.3) | |
Recurrences, No. (%) | 5 (1.8) | 22 (5.7) | .07 |
WLE margin taken, mean (SD), cm | |||
Recurred | NA | 0.9 (0.2) | .003 |
Not recurred | NA | 0.6 (0.04) | |
Time to recurrence, mean (SD), y | 3.91 (4.4) | 4.45 (2.7) | .73 |
Deaths, No. (%)c | |||
All cause | 37 (13.4) | 75 (19.5) | |
Melanoma specific | 2 (0.7) | 13 (3.4) | |
Time to death, mean (SD), y | |||
All cause | 18.4 (0.8) | 17.4 (0.4) | .28 |
Melanoma specific | 6.5 (4.8) | 6.1 (0.8) | .77 |
Abbreviations: IQR, interquartile range; MMS, Mohs micrographic surgery; NA, not applicable; WLE, wide local excision.
Preoperative assessment of 107 MMS-treated patients and 74 WLE-treated patients.
Assessment of 277 MMS-treated patients and 384 WLE-treated patients.
P values not given because a statistical test comparing the raw counts/percentages does not account for differential follow-up time (see time to death analyses).